Department of Genetic Metabolic Disease Screening
遗传代谢病筛查科 · Weifang Maternal and Child Health Hospital, Weifang
This department operates the Weifang Newborn Disease Screening Center, established in 2000. It screens live-born infants across Weifang for genetic and metabolic disorders using heel blood samples collected 72 hours after birth. The center utilizes advanced tandem mass spectrometry systems to detect conditions early, aiming to prevent lifelong disability. If initial results are abnormal, parents are notified for follow-up testing and professional treatment. Parents can query results online or via WeChat using the sample barcode. While the screening methods detect approximately 95% of cases, factors such as prematurity or low birth weight may affect accuracy. The department provides long-term management for confirmed positive cases.
Conditions and treatments
- Newborn genetic and metabolic disease screening
- Tandem mass spectrometry analysis
- Follow-up diagnosis for positive screening results
- Long-term treatment for confirmed genetic metabolic disorders
- Online and WeChat result queries
- Management of newborn screening networks
Key facts
- The Weifang Newborn Disease Screening Center was established in 2000.
- The screening laboratory uses WALLACTQD and QTRAP3200 tandem mass spectrometry systems.
- The screening method detects approximately 95% of affected infants.
Rewritten in English from the department's own description on a public doctor-listing platform. Claims such as "leading" are the hospital's own.
| Specialty | Endocrinology |
|---|---|
| Doctors listed | 2 |
| Chief physicians | — |
We are an independent coordination service, not part of this hospital. Names and titles change; the hospital's website is the final word. How we build this directory.
Need a specialist's opinion?
Send your records and question. We find a specialist in the right field who reviews your case and tells you what they recommend.
Contact us